Health Care/Hospital

Lunit INSIGHT MMG, an AI Solution for Breast Cancer Detection, Now CE Certified

SEOUL, South Korea, June 2, 2020 /PRNewswire/ -- Lunit today announced that its AI solution for breast cancer, Lunit INSIGHT MMG, has been CE certified. The medical software was certified onMay 26th, making it now commercially available across the European Economic Area. The certified software, ...

2020-06-02 16:00 1446

icometrix launches its icompanion platform for people with multiple sclerosis

LEUVEN, Belgium and CHICAGO, June 2, 2020 /PRNewswire/ -- icometrix, the world leader to extract clinically meaningful data from brain scans, is proud to have launched the icompanion platform and phone application for people with multiple sclerosis on World MS Day!  icompanion is a medical device...

2020-06-02 15:00 1704

Modular Bioscience Acquires Exclusive License to University of Illinois Urbana Champaign Artificial Restriction Enzyme Technology

SILICON VALLEY, Calif., June 2, 2020 /PRNewswire/ -- Modular Bioscience, an early stage biotechnology company based in Silicon Valley, today announced that it has executed a definitive agreement with theUniversity of Illinois at Urbana-Champaign for an exclusive global patent license to a novel a...

2020-06-02 13:28 1968

Adagio Medical Receives CE Mark Approval for its iCLAS(TM) Cryoablation System and Prepares for European Commercial Launch

LAGUNA HILLS, Calif., June 2, 2020 /PRNewswire/ -- Adagio Medical, Inc., announces that it has received CE Mark approval for its ultra-low temperaturei ntelligentContinuous Lesion Ablation System (iCLAS) for the endocardial treatment of paroxysmal (PAF) and persistent (PsAF) atrial fibrillation an...

2020-06-02 11:25 2008

icometrix launches its icompanion platform for people with multiple sclerosis

LEUVEN, Belgium and CHICAGO, June 2, 2020 /PRNewswire/ -- icometrix, the world leader to extract clinically meaningful data from brain scans, is proud to have launched the icompanion platform and phone application for people with multiple sclerosis on World MS Day!  icompanion is a medical device...

2020-06-02 08:00 1906

Innovent Announced the Preliminary Results of the Anti-PD-1/PD-L1 Bispecific Antibody IBI318 in a Phase 1 Clinical Study

SUZHOU, China, June 2, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic,  autoimmune and other major diseases, announced the ...

2020-06-02 07:30 6150

AGC Biologics Acquires Commercial Facility, Expanding Global Service Offerings

AGC Biologics acquires Boulder, Colorado U.S.A. facility to increase global capacity and extend manufacturing scale SEATTLE, June 2, 2020 /PRNewswire/ -- AGC Biologics, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the purchase of a state-of-the...

2020-06-02 06:00 3344

China Jo-Jo Drugstores Announces $10 Million Registered Direct Offering

HANGZHOU, China, June 1, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that it ha...

2020-06-01 21:25 10324

Cynosure Launches Elite iQ™ Aesthetic Workstation For Laser Hair Removal and Skin Revitalization in the United States, Europe and Australia

The World's First Alexandrite-ND: YAG System Now Upgraded with Skintel®, The Industry's Only Melanin Reader™ For More Customized Laser Hair Removal Treatments For All Skin Types WESTFORD, Massachusetts, June 1, 2020 /PRNewswire/ -- Cynosure announced today the U.S., European and Australian launc...

2020-06-01 20:45 2694

Alchera exports a preventive solution of COVID-19 to San Pedro Square Market, San Jose

SEOUL, South Korea, June 1, 2020 /PRNewswire/ -- Alchera, the leading high-tech company inSouth Korea and a member company of the Born2Global Centre, with the specialty of Artificial Intelligence (AI) on the facial recognition technology, exported the preventive solution ofCOVID-19 to San Pedro S...

2020-06-01 20:30 1673

Luye Pharma Enters Distribution and Marketing Partnerships in South Korea, Hong Kong, and Thailand for Seroquel® and Seroquel XR®

SHANGHAI, June 1, 2020 /PRNewswire/ -- Luye Pharma Group (Luye Pharma) today held a special signing ceremony as part of the "We Care About Mental Health" initiative, marking the start of three new strategic partnerships across the region. As part of the initiative, Luye Pharma granted Alvogen Kor...

2020-06-01 15:22 7964

Henlius and Accord Receive Positive CHMP Opinion for Oncology Biosimilar, HLX02 (Trastuzumab)

SHANGHAI, June 1, 2020 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) and Accord Healthcare Limited (Accord) jointly announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending marketing aut...

2020-06-01 13:48 3564

UOB intensifies COVID-19 safety measures by applying self-disinfecting coating at high-touch areas within its branches island-wide

SINGAPORE, June 1, 2020 /PRNewswire/ -- United Overseas Bank (UOB) today announced that it has enhanced the precautionary measures within its branches with the application of a commercial grade self-disinfecting coating at high-touch areas including branch counters and meeting areas. The initiati...

2020-06-01 11:53 4755

Uniview Temperature Screening Solutions Help Thailand Government to Fight Against COVID 19

BANGKOK, June 1, 2020 /PRNewswire/ -- In May, 2020, through the Ministry of Education, Ministry of Technology, and Prime Ministry's Office, Uniview provided enhanced temperature screening solutions and products, including CW-180, OET-213H-BTS1, and other Heat-Tracker series products, to help the ...

2020-06-01 11:34 2771

NCH Asia Pacific announces the specialized 'NCH Disinfection Program' to keep NCH customers' business running and protecting their customers

SINGAPORE, June 1, 2020 /PRNewswire/ -- NCH Asia Pacific, a global leader in industrial and commercial maintenance products and services since 1919, announced that it has launched a new'NCH Disinfection Program' to help businesses stay safe during the pandemic. COVID-19 haschanged lives and has ...

2020-06-01 09:00 2084

Kazia Presents Interim Paxalisib Phase II Data at ASCO Showing Positive Overall Survival Signal

SYDNEY, June 1, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share a poster presentation of interim data from the ongoing phase II study of paxalisib (formerly GDC-0084) in glioblastoma, the most comm...

2020-06-01 08:45 5124

Innovent Biologics Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (Nasal Type)

SUZHOU, China, May 31, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, announced ...

2020-06-01 07:30 1865

Innovent Biologics and Lilly Jointly Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Patients with Relapsed/Refractory Classic Hodgkin's Lymphoma

SUZHOU, China, May 31, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines, jointly announced with Eli Lilly and Company (Lilly) (NYSE: LLY) the research results of TY...

2020-06-01 07:30 1929

Innovent Biologics and Lilly Jointly Announced the Pivotal Clinical Study Results of TYVYT® (Sintilimab Injection) in the Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma

SUZHOU, China, May 31, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines, jointly announced with Eli Lilly and Company (Lilly) (NYSE: LLY) the results of TYVYT® (sin...

2020-06-01 07:30 2635

Innovent Biologics Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (Nasal Type)

SUZHOU, China, June 1, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, announced ...

2020-06-01 07:30 5174
1 ... 767768769770771772773 ... 847

Week's Top Stories